• Nachrichtendetail
• 

28.03.2024 13:34:18 - dpa-AFX: *GILEAD : FDA EXPANDS INDICATION FOR VEMLIDY TO TREAT CHRONIC HBV INFECTION IN PEDIATRIC PATIENTS AS YOUNG AS SIX

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	GILEAD SCIENCES DL-,001	885823	Xetra	58,000	19.06.24 10:45:01	-0,910	-1,54%	58,500	59,760	59,060	58,910